以岭药业：2025年半年度归属于上市公司股东的净利润同比增长26.03%

Core Insights - Yiling Pharmaceutical reported a revenue of 4,040,142,217.94 yuan for the first half of 2025, representing a year-on-year decline of 12.26% [1] - The net profit attributable to shareholders of the listed company was 668,535,024.73 yuan, showing a year-on-year increase of 26.03% [1] Financial Performance - The company's revenue decreased by 12.26% compared to the same period last year [1] - The net profit increased by 26.03% year-on-year, indicating improved profitability despite the revenue decline [1]